While we initially reported the involvement of MACC1-AS1 in gemcitabine resistance specifically in pancreatic cancer, subsequent studies have highlighted its role in promoting drug resistance in other types of cancer, including gastric cancer and esophageal squamous cell carcinoma [18, 19]. Here, MACC1 is linked to gastric cancer.